Business Context and Reporting Period
Company: Bond Laboratories, Inc. (Note: Metadata listed "FITLIFE BRANDS, INC." but the filing text identifies the issuer as Bond Laboratories, Inc., trading as BNLB).
Reporting Period: Quarterly Report (Form 10-Q) for the three and nine months ended September 30, 2010.
Business Overview: A national provider of nutritional supplements and beverage products operating through two primary divisions: NDS Nutrition Products (supplements sold via GNC) and Fusion Premium Beverages (health and energy drinks). The company is headquartered in Omaha, Nebraska.
Key Financial Metrics
| Metric | 9 Months Ended Sep 30, 2010 | 9 Months Ended Sep 30, 2009 |
|---|---|---|
| Revenue | $6,442,419 | $6,961,317 |
| Gross Profit | $1,857,901 | $1,735,350 |
| Gross Margin | 28.8% | 24.9% |
| Net Loss | $(1,580,656) | $(6,437,378) |
| Operating Loss | $(1,520,224) | $(6,443,258) |
| Cash Flow from Operations | $(1,080,027) | $(1,273,306) |
| Cash Balance (End of Period) | $213,647 | $1,290,219 |
| Total Debt (Current) | $1,299,801 | $1,058,564 |
Material Changes vs. Prior Period
- Revenue: Reported revenue decreased by 7.5% year-over-year. However, management notes that excluding discontinued product lines from the prior year, revenue from continuing operations actually increased by approximately 10%.
- Profitability: Net loss improved significantly, decreasing from $6.44 million in 2009 to $1.58 million in 2010. This improvement is largely attributed to the absence of a $4.82 million non-cash warrant issuance expense recorded in the prior year.
- Expense Reclassification: General and Administrative (G&A) expenses dropped drastically from $7.44 million to $1.79 million, while Selling and Marketing expenses rose from $0.53 million to $1.38 million. Management attributes this shift to the reclassification of expenses rather than a fundamental change in cost structure.
- Liquidity: Cash on hand decreased by approximately $822,000 during the nine-month period, dropping from $1.04 million to $213,647.
Guidance, Outlook, and Risks
- Capital Resources: Management anticipates having adequate working capital for the next twelve months following a subsequent event on November 15, 2010, where the company raised $1.25 million via the sale of Series C Convertible Preferred Stock.
- Debt Restructuring (Subsequent Event): On November 15, 2010, holders of $424,000 in Bridge Notes exchanged their debt for 2,638,812 shares of common stock. Additionally, the company entered into a new secured promissory note to replace an existing affiliate note.
- Legal Proceedings: The company is facing an ongoing complaint filed by a former President with the U.S. Department of Labor (OSHA) alleging unlawful employment practices and retaliatory termination. An adverse outcome could result in substantial penalties and resource diversion.
- Risk Factors: The company relies heavily on key customers (e.g., GNC) and faces competition in the nutritional supplement market. The filing includes standard forward-looking statement disclaimers regarding market demand and product performance.
Investor Verification Checklist
- Subsequent Financing: Verify the terms and impact of the $1.25 million Series C Preferred Stock issuance and the debt-for-equity swap of Bridge Notes that occurred after the period end (November 15, 2010).
- Expense Reclassification: Scrutinize the shift of $4.8 million+ in expenses from G&A to Selling/Marketing to ensure it reflects operational reality and is not an accounting maneuver to mask operating inefficiencies.
- OSHA Litigation: Monitor the status of the OSHA complaint regarding the former President, as a loss could materially impact cash reserves.
- Debt Maturity: Confirm the repayment schedule for the remaining $500,000 line of credit and the new affiliate note, given the low cash balance of $213,647 at period end.
- Discontinued Operations: Review the specific details of the product lines discontinued in Q3 2009 to validate the "organic growth" claim of 10% revenue increase.